A group lead by Prof. Horacio Cabral (Visiting Scientist of iCONM/Associate Professor of Bioengineering, Graduate School of Engineering, University of Tokyo) has discovered a new approach for the treatment of triple-negative breast cancer.
Click here for original story, Breaking down the shield preventing drugs and immune cells from entering intractable cancers
Source: Phys.org